ASTRAZEN

Astrazeneca Pharma India Share PriceAstraZeneca Pharma India

₹3187.45
-159.55 (-4.77%)
As on 30 March, 2023 | 17:59 BSE: 506820 NSE: ASTRAZEN

Astrazeneca Pharma India Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in AstraZeneca Pharma India

Start SIP

Astrazeneca Pharma India Share Price

  • Over 1 Month -4.7%
  • Over 3 Month -3.46%
  • Over 6 Month 6.17%
  • Over 1 Year 22.12%

Astrazeneca Pharma India Key Statistics

P/E Ratio 72.4
PEG Ratio 0.9
Market Cap Cr 7,969
Price to Book Ratio 15.6
EPS 23.8
Dividend 0.3
Relative Strength Index 36.57
Money Flow Index 36.85
MACD Signal -7.38
Average True Range 89.08

Astrazeneca Pharma India Investment Rating

  • Master Rating:
  • Astrazeneca Pharma India has an operating revenue of Rs. 950.23 Cr. on a trailing 12-month basis. An annual revenue de-growth of -1% needs improvement, Pre-tax margin of 10% is healthy, ROE of 12% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 11% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 96 which is a GREAT score indicating consistency in earnings, a RS Rating of 70 which is FAIR indicating the recent price performance, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 87 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

AstraZeneca Pharma India Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 250236232232
Operating Expenses Qtr Cr 213195204194
Operating Profit Qtr Cr 37412838
Depreciation Qtr Cr 4354
Interest Qtr Cr 0000
Tax Qtr Cr 101279
Net Profit Qtr Cr 29332028

Astrazeneca Pharma India Technicals

EMA & SMA

Current Price
₹3187.45
-159.55 (-4.77%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • 3320.89
  • 50 Day
  • 3333.97
  • 100 Day
  • 3309.51
  • 200 Day
  • 3233.65
  • 20 Day
  • 3325.19
  • 50 Day
  • 3346.8
  • 100 Day
  • 3356.35
  • 200 Day
  • 3203.11

Astrazeneca Pharma India Resistance and Support

PIVOT
₹3344.62
Resistance
First Resistance 3372.19
Second Resistance 3397.37
Third Resistance 3424.94
RSI 36.57
MFI 36.85
MACD Single Line -7.38
MACD -13.12
Support
First Resistance 3319.44
Second Resistance 3291.87
Third Resistance 3266.69

Astrazeneca Pharma India Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 28,200 1,446,378 51.29
Week 7,895 440,157 55.75
1 Month 5,715 350,221 61.28
6 Month 10,482 511,091 48.76

Astrazeneca Pharma India Result Highlights

AstraZeneca Pharma India Synopsis

NSE-Medical-Diversified

Astrazeneca Pharma I is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 805.60 Cr. and Equity Capital is Rs. 5.00 Cr. for the Year ended 31/03/2022. AstraZeneca Pharma India Ltd. is a Public Limited Listed company incorporated on 11/07/1979 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L24231KA1979PLC003563 and registration number is 003563.
Market Cap 7,969
Sales 950
Shares in Float 0.63
No of funds 89
Yield 0.25
Book Value 15.58
U/D Vol ratio 0.6
LTDebt / Equity
Alpha 0.1
Beta 0.68

AstraZeneca Pharma India

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 75%75%75%
Mutual Funds 1.22%1.09%1.07%
Insurance Companies 0.03%0.03%
Foreign Portfolio Investors 2.61%2.49%2.48%
Financial Institutions/ Banks
Individual Investors 18.56%18.54%18.63%
Others 2.61%2.85%2.79%

AstraZeneca Pharma India Management

Name Designation
Mr. Narayan K Seshadri Chairman & Ind.Director
Mr. Gagandeep Singh Bedi Executive Director
Mr. Rajesh Marwaha Executive Director
Mr. Ankush Nandra Non Executive Director
Ms. Weiying Sarah Wang Non Executive Director
Ms. Revathy Ashok Independent Director
Ms. Shilpa Shidhar Divekar Independent Director

Astrazeneca Pharma India Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

AstraZeneca Pharma India MF Shareholding

Name Amount(cr)
Nippon India Small Cap Fund - Growth 23910
Nippon India Nifty Smallcap 250 Index Fund Reg Gr 388
Motilal Oswal Nifty 500 Fund Regular Growth 372
Motilal Oswal Nifty Smallcap 250 Index Fund Regular Growth 313
SBI Nifty Smallcap 250 Index Fund Regular Growth 159

AstraZeneca Pharma India FAQs

What is Share Price of AstraZeneca Pharma India ?

AstraZeneca Pharma India share price is ₹3187 As on 30 March, 2023 | 17:45

What is the Market Cap of AstraZeneca Pharma India ?

The Market Cap of AstraZeneca Pharma India is ₹7968.6 Cr As on 30 March, 2023 | 17:45

What is the P/E ratio of AstraZeneca Pharma India ?

The P/E ratio of AstraZeneca Pharma India is 72.4 As on 30 March, 2023 | 17:45

What is the PB ratio of AstraZeneca Pharma India ?

The PB ratio of AstraZeneca Pharma India is 15.6 As on 30 March, 2023 | 17:45

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number